Correlation Between Salarius Pharmaceuticals and Curis

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Salarius Pharmaceuticals and Curis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salarius Pharmaceuticals and Curis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Salarius Pharmaceuticals and Curis Inc, you can compare the effects of market volatilities on Salarius Pharmaceuticals and Curis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salarius Pharmaceuticals with a short position of Curis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salarius Pharmaceuticals and Curis.

Diversification Opportunities for Salarius Pharmaceuticals and Curis

0.52
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Salarius and Curis is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Salarius Pharmaceuticals and Curis Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Curis Inc and Salarius Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salarius Pharmaceuticals are associated (or correlated) with Curis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Curis Inc has no effect on the direction of Salarius Pharmaceuticals i.e., Salarius Pharmaceuticals and Curis go up and down completely randomly.

Pair Corralation between Salarius Pharmaceuticals and Curis

Given the investment horizon of 90 days Salarius Pharmaceuticals is expected to generate 1.12 times more return on investment than Curis. However, Salarius Pharmaceuticals is 1.12 times more volatile than Curis Inc. It trades about -0.08 of its potential returns per unit of risk. Curis Inc is currently generating about -0.21 per unit of risk. If you would invest  167.00  in Salarius Pharmaceuticals on August 29, 2024 and sell it today you would lose (15.00) from holding Salarius Pharmaceuticals or give up 8.98% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy95.65%
ValuesDaily Returns

Salarius Pharmaceuticals  vs.  Curis Inc

 Performance 
       Timeline  
Salarius Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Salarius Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Salarius Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Curis Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Curis Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's forward indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Salarius Pharmaceuticals and Curis Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Salarius Pharmaceuticals and Curis

The main advantage of trading using opposite Salarius Pharmaceuticals and Curis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salarius Pharmaceuticals position performs unexpectedly, Curis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Curis will offset losses from the drop in Curis' long position.
The idea behind Salarius Pharmaceuticals and Curis Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stocks Directory
Find actively traded stocks across global markets
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.